BTL Medizintechnik GmbH v. Lexter Microelectronic Engineering Systems S.L.

GlaxoSmithKline Biologicals SAvsRespondent

GlaxoSmithKline Biologicals SA filed a patent infringement action against 14 Pfizer entities concerning European Patent EP 4 183 412 B1 before the Düsseldorf Local Division. Prior to the closure of the written procedure, the Claimant withdrew the infringement action, and the Defendants consented to the withdrawal and did not object to a 60% reimbursement of court fees. The Court allowed the withdrawal, declared the proceedings closed, and ordered the reimbursement of 60% of the court fees (EUR 201,600) to the Claimant.

10x Genomics, Inc.vsRespondent

In a patent infringement action concerning EP 2 697 391 B1 before the Düsseldorf Local Division, the Claimant 10x Genomics requested that the Defendant Curio Bioscience provide security for legal costs under Rule 158 RoP. The Defendant argued the application was inadmissible, contending that Art. 69(4) UPCA only permits defendants to request security from claimants. The Court held the application admissible and well-founded, ordering the Defendant to provide security of EUR 200,000 within four weeks, and granted leave to appeal.

TOTAL SEMICONDUCTOR, LLCvsRespondent

This procedural order concerns a patent infringement action involving European Patent No. EP 2 746 957. The claimant sought to file a further written pleading to respond to new arguments raised by the defendants in their rejoinder, but the judge-rapporteur dismissed this request on 1 April 2025. The claimant then filed an application for review pursuant to R. 333 RoP. The panel confirmed the judge-rapporteur's order and rejected the application for panel review, finding the request for a further written submission unfounded.

Motorola Mobility LLCvsRespondent

1 Local Division Munich UPC_CFI_41/2024 Order of the Court of First Instance of the Unified Patent Court in the main proceedings related to European Patent 3 780 758 delivered on 06/08/2024 Date of receipt of Statement of claim: 30/01/2024 Telefonaktiebolaget LM Ericsson (Defendant

Apple Retail Germany B.V. & Co. KGvsRespondent

This order concerns an application by Apple entities (the appellants and defendants in the main infringement proceedings) to accelerate the appeal proceedings and shorten the time limit for filing the respondent's appeal response under Rules 225(e) and 9.3(b) of the Rules of Procedure. The underlying dispute involves Apple's appeal of the Court of First Instance President's order dated June 18, 2024, which rejected Apple's request to change the language of proceedings from German to English (the language of the patent EP 2263098). The Court of Appeal rejected the acceleration request, finding that Apple's interests in acceleration did not outweigh Ona Patents' interest in orderly proceedings.